Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucoma

Acta Ophthalmologica

Volumn 88, Issue 5, 2010, Pages 541-552

  Martínez, Antonio ^a   Sanchez Salorio, Manuel ^a  

^a Galician Institute of Ophthalmology   (Spain)

Author keywords

brinzolamide timolol; dorzolamide timolol; ischaemia; primary open angle glaucoma; visual field progression

Indexed keywords

ANTIHYPERTENSIVE AGENT; BRINZOLAMIDE; DORZOLAMIDE; TIMOLOL;

AGED; ARTICLE; CILIARY ARTERY; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA THICKNESS; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OPEN ANGLE GLAUCOMA; OPHTHALMIC ARTERY; PERIMETRY; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VISUAL FIELD;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARBONIC ANHYDRASE INHIBITORS; CILIARY ARTERIES; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPHTHALMIC ARTERY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RETINAL ARTERY; RISK FACTORS; SULFONAMIDES; THIAZINES; THIOPHENES; TIMOLOL; TONOMETRY, OCULAR; ULTRASONOGRAPHY, DOPPLER, COLOR; VISION DISORDERS; VISUAL FIELDS;

EID: 77954643960     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01595.x     Document Type: Article

References (83)

1. Adamsons IA, Polis AB, Ostrov CS, Boyle JE Dorzolamide Safety Study Group (1998 Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. J Glaucoma 7 : 395 401.
2. Advanced Glaucoma Intervention Study Investigators (2000 The Advanced Glaucoma Intervention Study (AGIS) (7). The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130 : 429 440.
3. Advanced Glaucoma Intervention Study Investigators (2002 The Advanced Glaucoma Intervention Study (AGIS) (12). Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol 134 : 499 512.
4. Armaly MF, Krueger DE, Maunder L et al. (1980 Biostatistical analysis of the Collaborative Glaucoma Study I. Summary report of the risk factors for glaucomatous visual field defects. Arch Ophthalmol 98 : 2163 2171.
5. Asman P Heijl A (1992 Glaucoma Hemifield Test. Automated visual field evaluation. Arch Ophthalmol 110 : 812 819.
6. Avunduk AM, Sari A, Akyol N, Oztürk O, Kapicioglu Z Erdöl H (2001 The 1-month effects of topical betaxolol, dorzolamide and apraclonidine on ocular blood flow velocities in patients with newly diagnosed primary open-angle glaucoma. Ophthalmologica 215 : 361 365.
7. Bengtsson B, Leske MC, Hyman L, Heijl A Early Manifest Glaucoma Trial Group (2007 Fluctuation of intraocular pressure and glaucoma progression in the Early Manifest Glaucoma Trial. Ophthalmology 114 : 205 209. (Pubitemid 46161799)
8. Bergstrand IC, Heijl A Harris A (2002 Dorzolamide and ocular blood flow in previously untreated glaucoma patients: a controlled double-masked study. Acta Ophthalmol Scand 80 : 176 182.
9. Boyle JE, Ghosh K, Gieser DK Adamsons IA (1998 A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group. Ophthalmology 105 (10 1945 1951.
10. Chauhan BC (2007 Choosing end-points in clinical studies and trials. Eye 21 (Suppl.) : 34 37.
11. Chauhan BC, Mikelberg FS, Balaszi AG, Le Blanc RP, Lesk MR, Trope GE Canadian Glaucoma Study Group (2008 Canadian Glaucoma Study 2: risk factors for the progression of open-angle glaucoma. Arch Ophthalmol 126 : 1030 1036.
12. Chen PP (2002 Correlation of visual field progression between eyes in patients with open-angle glaucoma. Ophthalmology 109 : 2093 2099.
13. Chen PP Bhandari A (2000 Fellow eye prognosis in patients with severe visual field loss in one eye from chronic open-angle glaucoma. Arch Ophthalmol 118 : 473 478.
14. Chen PP Park RJ (2000 Visual field progression in patients with initially unilateral visual field loss from chronic open-angle glaucoma. Ophthalmology 107 : 1688 1692.
15. Chow S Ruskey E (2004 Drawing area-proportional Venn and Euler diagrams. In: Proc. of Graph Drawing 2003. Spring-Verlag LNCS 2912. 466 477.
16. Clineschmidt CM, Williams RD, Snyder E Adamsons IA (1998 A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Dorzolamide-Timolol Combination Study Group. Ophthalmology 105 (10 1952 1959.
17. Dong J Chihara E (2001 Slope analysis of the optic disc in eyes with ocular hypertension and early normal-tension glaucoma by confocal scanning laser ophthalmoscope. Br J Ophthalmol 85 : 56 62.
18. Drance SM Rojanapongpun P (1995 The ophthalmic artery velocity in open-angle glaucoma. In : Drance SM (ed Update to Glaucoma, Ocular Blood Flow, and Drug Treatment.
19. Drance S, Anderson DR, Schulzer M Collaborative Normal-Tension Glaucoma Study Group (2001 Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 131 : 699 708.
20. European Glaucoma Prevention Study (EGPS) Group (2005 Results of the European Glaucoma Prevention Study. Ophthalmology 112 : 366 375.
21. European Glaucoma Prevention Study (EGPS) Group (2007 Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology 114 : 3 9.
22. Fitzke FW, Hitchings RA, Poinoosawmy D, McNaught AI Crabb DP (1996 Analysis of visual field progression in glaucoma. Br J Ophthalmol 80 : 40 48.
23. 2 during prolonged acetazolamide treatment in humans. Am J Physiol 258 : 954 959.
24. Friedman E Chandra SR (1972 Choroidal blood flow: effects of oxygen and carbon dioxide. Arch Ophthalmol 87 : 70 71.
25. Fuchsjäger-Mayrl G, Wally B, Rainer G et al. (2005 Effect of dorzolamide and timolol on ocular blood flow in patients with primary open-angle glaucoma and ocular hypertension. Br J Ophthalmol 89 : 1293 1297. (Pubitemid 41638868)
26. Galassi F, Sodi A, Renieri G, Ucci F, Pieri B, Harris A Siesky B (2002 Effects of timolol and dorzolamide on retrobulbar haemodynamics in patients with newly diagnosed primary open-angle glaucoma. Ophthalmologica 216 : 123 128.
27. Galassi F, Sodi A, Ucci F, Renieri G, Pieri B Baccini M (2003 Ocular haemodynamics and glaucoma prognosis: a colour Doppler imaging study. Arch Ophthalmol 121 : 1711 1715.
28. Gordon MO, Beiser JA, Brand JD et al. (2002 The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120 : 714 720.
29. Grant WM Burke JF Jr. (1982 Why do some people go blind from glaucoma? Ophthalmology 89 : 991 998.
30. Grunwald JE, Mathur S DuPont J (1997 Effects of dorzolamide hydrochloride 2% on the retinal circulation. Acta Ophthalmol 75 : 236 238.
31. Hageman GS, Zhu XL, Waheed A Sly WS (1991 Localization of carbonic anhydrase IV in a specific capillary bed of the human eye. Proc Natl Acad Sci U S A 88 : 2716 2720.
32. Hodapp E, Parrish R Anderson D (1993 Clinical Decisions in Glaucoma.
33. Holmin C Krakau CE (1982 Regression analyses of the central visual field in chronic glaucoma cases: a follow-up study using automatic perimetry. Acta Ophthalmol (Copenh) 60 : 267 274.
34. Inoue J, Oka M, Aoyama Y, Kobayashi S, Ueno S, Hada N, Takeda T Takehana M (2004 Effects of dorzolamide hydrochloride on ocular tissues. J Ocul Pharmacol Ther 20 : 1 13.
35. Jansonius NM Heeg GP (2009 The Groningen Longitudinal Glaucoma Study II. A prospective comparison of frequency doubling perimetry, the GDx nerve fibre analyser and standard automated perimetry in glaucoma suspect patients. Acta Ophthalmol 87 : 429 432.
36. Janulovicienë I, Harris A, Kagemann L, Siesky B Mc Cranor L (2004 A comparison of the effects of dorzolamide/timolol fixed combination versus letterpress in intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients. Acta Ophthalmol Scand 82 : 730 737.
37. Josefsson A, Sigurdsson SB, Bang K Eysteinsson T (2004 Dorzolamide induces vasodilatation in isolated pre-contracted bovine retinal arteries. Exp Eye Res 78 : 215 221.
38. Katz J, Zeger S Liang KY (1994 Appropriate statistical methods to account for similarities in binary outcomes between fellow eyes. Invest Ophthalmol Vis Sci 35 : 2461 2465.
39. Katz J, Gilbert D, Quigley HA Sommer A (1997 Estimating progression of visual field loss in glaucoma. Ophthalmology 104 : 1017 1025.
40. Katz J, Congdon N Friedman DS (1999 Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment. Arch Ophthalmol 117 : 1137 1142. (Pubitemid 29428821)
41. Kaup M, Plange N, Niegel M, Remky A Arend O (2004 Effects of brinzolamide on ocular haemodynamics in healthy volunteers. Br J Ophthalmol 88 : 257 262.
42. Kehler AK, Holmgaard K, Hessellund A, Aalkjaer C Bek T (2007 Variable involvement of the perivascular retinal tissue in carbonic anhydrase inhibitor-induced relaxation of porcine retinal arterioles in vitro. Invest Ophthalmol Vis Sci 48 : 4688 4693.
43. Lass JH, Khosrof SA, Laurence JK, Horwitz B, Ghosh K Adamsons I (1998 A double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol, and betaxolol. Dorzolamide Corneal Effects Study Group. Arch Ophthalmol 116 : 1003 1010.
44. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E Early Manifest Glaucoma Trial Group (2003 Factors for glaucoma progression and the effect of treatment (the Early Manifest Glaucoma Trial). Arch Ophthalmol 121 : 48 56.
45. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z EMGT Group (2007 Predictors of longterm progression in the Early Manifest Glaucoma Trial. Ophthalmology 114 : 1965 1972.
46. Lieb WE, Cohen SM, Merton DA, Shields JA, Mitchell DG Goldberg BB (1991 Colour Doppler imaging of the eye and orbit: technique and normal vascular anatomy. Arch Ophthalmol 109 : 527 531.
47. March WF Ochsner KI (2000 The longterm safety and efficacy of brinzolamide 1.0% (Azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Longterm Therapy Study Group. Am J Ophthalmol 129 : 136 143.
48. Martinez A Sanchez M (2005 Predictive value of colour Doppler imaging in a prospective study of visual field progression in primary open-angle glaucoma. Acta Ophthalmol Scand 83 : 716 723.
49. Martinez A Sanchez M (2006 A comparison of the effects of 0.005% latanoprost and fixed combination dorzolamide/timolol on retrobulbar haemodynamics in previously untreated glaucoma patients. Curr Med Res Opin 22 : 67 73.
50. Martinez A Sanchez M (2007 Retrobulbar haemodynamic effects of the latanoprost/ timolol and the dorzolamide/timolol fixed combinations in newly diagnosed glaucoma patients. Int J Clin Pract 61 (5 815 821.
51. Martinez A Sanchez M (2008a Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and progression of visual field damage in patients with primary open-angle glaucoma: a single-centre, 4-year, open-label study. Clin Ther 30 : 1120 1134.
52. Martinez A Sanchez M (2008b Ocular haemodynamics in pseudoexfoliative and primary open-angle glaucoma. Eye 22 (4 515 520.
53. Martinez A Sanchez M (2008c Retrobulbar haemodynamic parameters in pseudoexfoliation syndrome and pseudoexfoliative glaucoma. Graefes Arch Clin Exp Ophthalmol 246 : 1341 1349.
54. Martinez A, Gonzalez F, Capeans C, Perez R Sanchez-Salorio M (1999 Dorzolamide effect on the ocular blood flow. Invest Ophthalmol Vis Sci 40 : 1270 1275.
55. Müskens RPHM, De Voogd S, Wolfs RC, Witteman JC, Hofman A, de Jong PT, Stricker BH Jansonius NM (2007 Systemic antihypertensive medication and incident open-angle glaucoma. Ophthalmology 114 : 2221 2226.
56. Nagelhus EA, Mathiisen TM, Bateman AC, Haug FM, Ottersen OP, Grubb JH, Waheed A Sly WS (2005 Carbonic anhydrase XIV is rich in specific membrane domains of retinal pigment epithelium, Müller cells, and astrocytes. Proc Natl Acad Sci U S A 102 : 8030 8035.
57. Nakagami T, Yamazaki Y Hayamizu F (2006 Prognostic factors for progression of visual field damage in patients with normal-tension glaucoma. Jpn J Ophthalmol 50 : 38 43.
58. Nouri-Mahdavi K, Hoffman D, Coleman AL, Liu G, Li G, Gaasterland D, Caprioli J Advanced Glaucoma Intervention Study (2004a Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 111 : 1627 1635.
59. Nouri-Mahdavi K, Hoffman D, Gaasterland D Caprioli J (2004b Prediction of visual field progression in glaucoma. Invest Ophthalmol Vis Sci 45 : 4346 4351.
60. Nouri-Mahdavi K, Hoffman D, Ralli M Caprioli J (2007 Comparison of methods to predict visual field progression in glaucoma. Arch Ophthalmol 129 : 1176 1181.
61. Ornek K, Gullu R, Ogurel T Ergin A (2008 Short-term effect of topical brinzolamide on human central corneal thickness. Eur J Ophthalmol 18 : 338 340.
62. Ozturk F, Ermis SS Inan UU (2007 Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study. Acta Ophthalmol Scand 85 : 80 83.
63. Pillunat LE, Böhm AG, Köller AU, Schmidt KG, Klemm M Richard G (1999 Effect of topical dorzolamide on optic nerve head blood flow. Graefes Arch Clin Exp Ophthalmol 237 : 495 500. (Pubitemid 29253544)
64. Pourcelot L (1975 Indications de l'ultrasonographie Doppler dans l'etude des vaisseaux peripheriques. Rev Prat 25 : 4671 4680.
65. Riva CE Petrig BL (1995 Choroidal blood flow by laser Doppler flowmetry. Opt Eng 34 : 746 752.
66. Satilmis M, Orgul S, Doubler B Flammer J (2003 Rate of progression of glaucoma correlates with retrobulbar circulation and intraocular pressure. Am J Ophthalmol 135 : 664 669.
67. Sato S, Hirooka K, Baba T, Yano I Shiraga F (2008 Correlation between retinal nerve fibre layer thickness and retinal sensitivity. Acta Ophthalmol 86 : 609 613.
68. 2 on ocular fundus pulsations. Exp Eye Res 63 : 351 355. (Pubitemid 26366762)
69. Sender S, Gros G, Waheed A, Hageman GS Sly WS (1994 Immunohistochemical localization of carbonic anhydrase IV in capillaries of rat and human skeletal muscle. J Histochem Cytochem 42 : 1229 1236.
70. Shall K Brinzolamide Primary Therapy Study Group (2000 The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension. Surv Ophthalmol 44 : 155 162.
71. Siesky B, Harris A, Cantor LB et al. (2008 A comparative study of the effects of brinzolamide and dorzolamide on retinal oxygen saturation and ocular microcirculation in patients with primary open-angle glaucoma. Br J Ophthalmol 92 : 500 504.
72. Silver LH (1998 Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension Brinzolamide Primary Therapy Study Group. Am J Ophthalmol 126 : 400 408.
73. Spry PGD, Sparrow JM, Diamond JP Harris HS (2005 Risk factors for progressive visual field loss in primary open-angle glaucoma. Eye 19 : 643 651.
74. Stams T, Chen Y, Boriack-Sjodin PA et al. (1998). Structures of murine carbonic anhydrase IV and human carbonic anhydrase II complexes with brinzolamide: molecular basis of isoenzyme-drug discrimination. Protein Sci 7 : 556 563.
75. Stewart WC, Kolker AE, Sharpe ED, Day DG, Holmes KT, Leech JN, Johnson M Cantrell JB (2000 Factors associated with longterm progression or stability in primary open-angle glaucoma. Am J Ophthalmol 130 : 274 279.
76. Strahlman E, Tipping R, Vogel R International Dorzolamide Study Group (1995). A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. Arch Ophthalmol 113 : 1009 1016.
77. Sugrue MF (2000 Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors. Prog Retin Eye Res 19 : 87 112.
78. Vesti E, Johnson CA Chauhan BC (2003 Comparison of different methods for detecting glaucomatous visual field progression. Invest Ophthalmol Vis Sci 44 : 3873 3879.
79. Weinstock FJ (1973 Ophthalmic hazards of hypotensive drugs. JAMA 224 : 1039.
80. Wirtitsch MG, Findl O, Kiss B, Petternel V, Heinzl H Drexler W (2003 Short-term effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata. Arch Ophthalmol 121 : 621 625.
81. Wirtitsch MG, Findl O, Heinzl H Drexler W (2007 Effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata. Arch Ophthalmol 125 (10 1345 1350.
82. Wistrand PJ (2000 Carbonic anhydrase inhibition in ophthalmology: carbonic anhydrases in cornea, lens, retina and lacrimal gland. EXS 90 : 413 424.
83. Zeitz O, Galambos P, Weirmann A et al. (2006 Glaucoma progression is associated with decreased blood flow velocities in the short posterior ciliary artery. Br J Ophthalmol 90 : 1245 1248.